Vision loss is a growing concern in India, especially macular degeneration - a common eye condition. Once known to be ...

Polygenic diseases company Character Biosciences has announced an oversubscribed $93 million Series B financing round to ...

Character Biosciences has raised $93m in an oversubscribed Series B funding round to expedite the progression of precision ...

Character Biosciences has raised $93m in an oversubscribed Series B round to speed the clinical development of a pipeline of ...

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

Opthea was making preparations for the potential launch of a new eye disease drug onto the market. | A month ago, Opthea was ...

A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...

To apply a precision medicine approach to this disease, Character Bio has partnered with over 150 ophthalmology treatment ...

Another example of disease-specific dietary recommendations ... been associated with a reduced risk of cataract, AMD and other age-related eye conditions, according to the American Academy ...

Co-led by new investors aMoon and Luma Group, Bausch + Lomb, Jefferson Life Sciences and others also participated in the funding, which will accelerate the advancement of pipeline precision therapies ...

The Eylea franchise was in need of a win after an appellate court last week denied the pharma’s bid to block Amgen’s ...